<DOC>
	<DOCNO>NCT00803452</DOCNO>
	<brief_summary>This prospective , randomize , comparative clinical trial evaluate effect either oral doxycycline , oral essential fatty acid , topical azithromycin modify secretion meibomian gland subject meibomian gland dysfunction and/or dry eye disease .</brief_summary>
	<brief_title>Lipids Human Tear Film Their Effect Tear Stability</brief_title>
	<detailed_description>Subjects meibomian gland dysfunction undergo expression meibomian gland secretion prior begin treatment either oral doxycycline , oral essential fatty acid , topical azithromycin solution . Doxycycline dose 100 mg bid ; essential fatty acid dose 1000 mg per day ; topical azithromycin deliver per day 1 % solution . Treatment doxycycline two month ; treatment essential fatty acid two month ; treatment topical azithromycin one month . Following treatment , meibomian gland express lipid measure spectroscopy ( FTIR , MALDI-TOF , NMR ) characterization structure function . Analysis presence doxcycline azithromycin also perform . Changes lipid parameter correlate clinical sign symptom disease .</detailed_description>
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Meibomian gland dysfunction Lid margin scar ; herpetic blepharitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Meibomian gland dysfunction</keyword>
	<keyword>Lid margin disease</keyword>
	<keyword>doxycycline</keyword>
	<keyword>azithromycin</keyword>
	<keyword>essential fatty acid</keyword>
</DOC>